CATALYST DOSSIER · UPDATED 2026-10-12
$ATAI
biotech · convergence -22 · conviction AVOID
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $ATAI?
Quantitative
Convergence score : -22 (1 signals firing YoY)
Catalysts
Multi-spoke convergence : 1 convergent signals fired: biotech
Risks
Position-sizing discipline : Conviction AVOID (-22 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Multiple compression : If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis
Sympathy basket (cerebro)
NFE via utilities r=-0.57 divergent (score 20)
VIVK via utilities r=-0.57 divergent (score -4)
KPTI via biotech r=+0.00 intra-sector (score 11)
BRVO via biotech r=+0.00 intra-sector (score 5)
PDSB via biotech r=+0.00 intra-sector (score 1)
JAZZ via biotech r=+0.00 intra-sector (score 0)
Sympathy Basket NFE via utilities · score 20 VIVK via utilities · score -4 KPTI via biotech · score 11 BRVO via biotech · score 5 PDSB via biotech · score 1 JAZZ via biotech · score 0
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.